{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:58:50Z","timestamp":1793091530859,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000888","name":"W. M. Keck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41386-022-01364-8","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T06:03:09Z","timestamp":1661148189000},"page":"797-805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Acute administration of ketone beta-hydroxybutyrate downregulates 7T proton magnetic resonance spectroscopy-derived levels of anterior and posterior cingulate GABA and glutamate in healthy adults"],"prefix":"10.1038","volume":"48","author":[{"given":"Antoine","family":"Hone-Blanchet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botond","family":"Antal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lithen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Stufflebeam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3752-5519","authenticated-orcid":false,"given":"Lilianne R.","family":"Mujica-Parodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Ratai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"1364_CR1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","volume":"21","author":"D Attwell","year":"2001","unstructured":"Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001;21:1133\u201345.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1364_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","volume":"36","author":"P Mergenthaler","year":"2013","unstructured":"Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013;36:587\u201397.","journal-title":"Trends Neurosci"},{"key":"1364_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40336-013-0026-y","volume":"1","author":"L Mosconi","year":"2013","unstructured":"Mosconi L. Glucose metabolism in normal aging and Alzheimer\u2019s disease: methodological and physiological considerations for PET studies. Clin Transl imaging. 2013;1:217\u201333.","journal-title":"Clin Transl imaging"},{"key":"1364_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/acn3.530","volume":"5","author":"R Mullins","year":"2018","unstructured":"Mullins R, Reiter D, Kapogiannis D. Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer\u2019s brain. Ann Clin Transl Neurol. 2018;5:262\u201372.","journal-title":"Ann Clin Transl Neurol"},{"key":"1364_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1474-4422(10)70277-5","volume":"10","author":"D Kapogiannis","year":"2011","unstructured":"Kapogiannis D, Mattson MP. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer\u2019s disease. Lancet Neurol. 2011;10:187\u201398.","journal-title":"Lancet Neurol"},{"key":"1364_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neurobiolaging.2017.10.023","volume":"63","author":"M Wirth","year":"2018","unstructured":"Wirth M, Bejanin A, La Joie R, Arenaza-Urquijo EM, Gonneaud J, Landeau B, et al. Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer\u2019s disease. Neurobiol aging. 2018;63:140\u201351.","journal-title":"Neurobiol aging"},{"key":"1364_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neurobiolaging.2007.05.019","volume":"30","author":"G Kalpouzos","year":"2009","unstructured":"Kalpouzos G, Ch\u00e9telat G, Baron JC, Landeau B, Mevel K, Godeau C, et al. Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol aging. 2009;30:112\u201324.","journal-title":"Neurobiol aging"},{"key":"1364_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1196\/annals.1427.007","volume":"1147","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Pupi A, De Leon MJ. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease. Ann N Y Acad Sci. 2008;1147:180\u2013195.","journal-title":"Ann N Y Acad Sci"},{"key":"1364_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jagp.2020.06.006","volume":"29","author":"J Krell-Roesch","year":"2021","unstructured":"Krell-Roesch J, Syrjanen JA, Vassilaki M, Lowe VJ, Vemuri P, Mielke MM, et al. Brain regional glucose metabolism, neuropsychiatric symptoms, and the risk of incident mild cognitive impairment: the Mayo Clinic study of aging. The. Am J Geriatr Psychiatry. 2021;29:179\u201391.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1364_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-020-1079-x","volume":"3","author":"TC Hammond","year":"2020","unstructured":"Hammond TC, Xing X, Wang C, Ma D, Nho K, Crane PK, et al. \u03b2-amyloid and tau drive early Alzheimer\u2019s disease decline while glucose hypometabolism drives late decline. Commun Biol. 2020;3:1\u201313.","journal-title":"Commun Biol"},{"key":"1364_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1006\/exnr.2000.7342","volume":"162","author":"M Higuchi","year":"2000","unstructured":"Higuchi M, Tashiro M, Arai H, Okamura N, Hara S, Higuchi S, et al. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol. 2000;162:247\u201356.","journal-title":"Exp Neurol"},{"key":"1364_CR12","first-page":"215","volume":"47","author":"A Ciarmiello","year":"2006","unstructured":"Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease. J Nucl Med. 2006;47:215\u201322.","journal-title":"J Nucl Med"},{"key":"1364_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","volume":"88","author":"MJ Firbank","year":"2017","unstructured":"Firbank MJ, Yarnall AJ, Lawson RA, Duncan GW, Khoo TK, Petrides GS, et al. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. J Neurol, Neurosurg Psychiatry. 2017;88:310\u2013316.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"1364_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms15259","volume":"8","author":"J Ruud","year":"2017","unstructured":"Ruud J, Steculorum SM, Br\u00fcning JC. Neuronal control of peripheral insulin sensitivity and glucose metabolism. Nat Commun. 2017;8:1\u201312.","journal-title":"Nat Commun"},{"key":"1364_CR15","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jalz.2013.12.008","volume":"10","author":"SM Steculorum","year":"2014","unstructured":"Steculorum SM, Solas M, Br\u00fcning JC. The paradox of neuronal insulin action and resistance in the development of aging\u2010associated diseases. Alzheimer\u2019s Dement. 2014;10:S3\u2013S11.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1364_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cmet.2016.07.010","volume":"24","author":"PJ Cox","year":"2016","unstructured":"Cox PJ, Kirk T, Ashmore T, Willerton K, Evans R, Smith A, et al. Nutritional ketosis alters fuel preference and thereby endurance performance in athletes. Cell Metab. 2016;24:256\u201368.","journal-title":"Cell Metab"},{"key":"1364_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1172\/JCI105650","volume":"46","author":"OE Owen","year":"1967","unstructured":"Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J Clin Investig. 1967;46:1589\u201395.","journal-title":"J Clin Investig"},{"key":"1364_CR18","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1177\/0271678X16669366","volume":"37","author":"A Courchesne-Loyer","year":"2017","unstructured":"Courchesne-Loyer A, Croteau E, Castellano CA, St-Pierre V, Hennebelle M, Cunnane SC. Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: a dual tracer quantitative positron emission tomography study. J Cereb Blood Flow Metab. 2017;37:2485\u201393.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1364_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2337\/diab.21.1.50","volume":"21","author":"J Flatt","year":"1972","unstructured":"Flatt J. On the maximal possible rate of ketogenesis. Diabetes. 1972;21:50\u201353.","journal-title":"Diabetes"},{"key":"1364_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1172\/JCI107584","volume":"53","author":"GA Reichard Jr","year":"1974","unstructured":"Reichard GA Jr., Owen OE, Haff AC, Paul P, Bortz WM. Ketone-body production and oxidation in fasting obese humans. J Clin Investig. 1974;53:508\u201315.","journal-title":"J Clin Investig"},{"key":"1364_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12999","volume":"1367","author":"SC Cunnane","year":"2016","unstructured":"Cunnane SC, Courchesne-Loyer A, St-Pierre V, Vandenberghe C, Pierotti T, Fortier M, et al. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer\u2019s disease. Ann N. Y Acad Sci. 2016;1367:12\u201320.","journal-title":"Ann N. Y Acad Sci"},{"key":"1364_CR22","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1073\/pnas.1913042117","volume":"117","author":"LR Mujica-Parodi","year":"2020","unstructured":"Mujica-Parodi LR, Amgalan A, Sultan SF, Antal B, Sun X, Skiena S, et al. Diet modulates brain network stability, a biomarker for brain aging, in young adults. Proc Natl Acad Sci. 2020;117:6170\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"1364_CR23","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3390\/nu13072134","volume":"13","author":"Y Yomogida","year":"2021","unstructured":"Yomogida Y, Matsuo J, Ishida I, Ota M, Nakamura K, Ashida K, et al. An fMRI investigation into the effects of ketogenic medium-chain triglycerides on cognitive function in elderly adults: a pilot study. Nutrients. 2021;13:2134.","journal-title":"Nutrients"},{"key":"1364_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.exger.2018.07.009","volume":"111","author":"N Torosyan","year":"2018","unstructured":"Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, et al. Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer\u2019s disease: results of a randomized, double-blinded, pilot study. Exp Gerontol. 2018;111:118\u201321.","journal-title":"Exp Gerontol"},{"key":"1364_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neulet.2018.10.048","volume":"690","author":"M Ota","year":"2019","unstructured":"Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, et al. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer\u2019s disease. Neurosci Lett. 2019;690:232\u20136.","journal-title":"Neurosci Lett"},{"key":"1364_CR26","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3233\/JAD-180995","volume":"68","author":"J Brandt","year":"2019","unstructured":"Brandt J, Buchholz A, Henry-Barron B, Vizthum D, Avramopoulos D, Cervenka MC. Preliminary report on the feasibility and efficacy of the modified Atkins diet for treatment of mild cognitive impairment and early Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2019;68:969\u201381.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1364_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jalz.2018.12.017","volume":"15","author":"M Fortier","year":"2019","unstructured":"Fortier M, Castellano CA, Croteau E, Langlois F, Bocti C, St-Pierre V, et al. A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimer\u2019s Dement. 2019;15:625\u201334.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1364_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neurobiolaging.2010.10.006","volume":"33","author":"R Krikorian","year":"2012","unstructured":"Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol aging. 2012;33:425\u2013e19-425. e27","journal-title":"Neurobiol aging"},{"key":"1364_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbacli.2015.01.001","volume":"3","author":"CJ Rebello","year":"2015","unstructured":"Rebello CJ, Keller JN, Liu AG, Johnson WD, Greenway FL. Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: a randomized controlled trial. BBA Clin. 2015;3:123\u20135.","journal-title":"BBA Clin"},{"key":"1364_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0197-4580(03)00087-3","volume":"25","author":"MA Reger","year":"2004","unstructured":"Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, et al. Effects of \u03b2-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol aging. 2004;25:311\u2013314.","journal-title":"Neurobiol aging"},{"key":"1364_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnmol.2016.00053","volume":"9","author":"SC Cunnane","year":"2016","unstructured":"Cunnane SC, Courchesne-Loyer A, Vandenberghe C, St-Pierre V, Fortier M, Hennebelle M, et al. Can ketones help rescue brain fuel supply in later life? Implications for cognitive health during aging and the treatment of Alzheimer\u2019s disease. Front Mol Neurosci. 2016;9:53.","journal-title":"Front Mol Neurosci"},{"key":"1364_CR32","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3233\/JAD-141074","volume":"43","author":"C-A Castellano","year":"2015","unstructured":"Castellano C-A, Nugent S, Paquet N, Tremblay S, Bocti C, Lacombe G, et al. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer\u2019s disease dementia. J Alzheimer\u2019s Dis. 2015;43:1343\u201353.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1364_CR33","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1001\/jama.1925.02660520007003","volume":"84","author":"M Peterman","year":"1925","unstructured":"Peterman M. The ketogenic diet in epilepsy. J Am Med Assoc. 1925;84:1979\u201383.","journal-title":"J Am Med Assoc"},{"key":"1364_CR34","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1542\/peds.102.6.1358","volume":"102","author":"JM Freeman","year":"1998","unstructured":"Freeman JM, Vining EPG, Pillas DJ, Pyzik PL, Casey JC, Kelly MT. The efficacy of the ketogenic diet\u20141998: a prospective evaluation of intervention in 150 children. Pediatrics. 1998;102:1358\u201363.","journal-title":"Pediatrics"},{"key":"1364_CR35","unstructured":"Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo Clin Bull. 1921;2:307\u20138."},{"key":"1364_CR36","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archneur.55.11.1433","volume":"55","author":"EP Vining","year":"1998","unstructured":"Vining EP, Freeman JM, Ballaban-Gil K, Camfield CS, Camfield PR, Holmes GL, et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol. 1998;55:1433\u20137.","journal-title":"Arch Neurol"},{"key":"1364_CR37","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00381-020-04578-7","volume":"36","author":"J Sourbron","year":"2020","unstructured":"Sourbron J, Klinkenberg S, van Kuijk S, Lagae L, Lambrechts D, Braakman H, et al. Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis. Child\u2019s Nerv Syst. 2020;36:1099\u2013109.","journal-title":"Child\u2019s Nerv Syst"},{"key":"1364_CR38","doi-asserted-by":"crossref","unstructured":"Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database of Syst Rev. 2016;2:CD001903.","DOI":"10.1002\/14651858.CD001903.pub3"},{"key":"1364_CR39","doi-asserted-by":"crossref","unstructured":"Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug\u2010resistant epilepsy. Cochrane Database of Syst Rev. 2020;6:CD001903.","DOI":"10.1002\/14651858.CD001903.pub5"},{"key":"1364_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.eplepsyres.2017.03.002","volume":"132","author":"B Wijnen","year":"2017","unstructured":"Wijnen B, de Kinderen R, Lambrechts D, Postulart D, Aldenkamp AP, Majoie M, et al. Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy. Epilepsy Res. 2017;132:91\u20139.","journal-title":"Epilepsy Res"},{"key":"1364_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08055-1","volume":"7","author":"T Yamanashi","year":"2017","unstructured":"Yamanashi T, Iwata M, Kamiya N, Tsunetomi K, Kajitani N, Wada N, et al. Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses. Sci Rep. 2017;7:1\u201311.","journal-title":"Sci Rep"},{"key":"1364_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78410-2","volume":"10","author":"T Yamanashi","year":"2020","unstructured":"Yamanashi T, Iwata M, Shibushita M, Tsunetomi K, Nagata M, Kajitani N, et al. Beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, attenuates anxiety-related behavior in a rodent post-traumatic stress disorder model. Sci Rep. 2020;10:1\u201311.","journal-title":"Sci Rep"},{"key":"1364_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"Y-H Youm","year":"2015","unstructured":"Youm Y-H, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome\u2013mediated inflammatory disease. Nat Med. 2015;21:263\u20139.","journal-title":"Nat Med"},{"key":"1364_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","volume":"39","author":"CD Rae","year":"2014","unstructured":"Rae CD. A guide to the metabolic pathways and function of metabolites observed in human brain 1 H magnetic resonance spectra. Neurochem Res. 2014;39:1\u201336.","journal-title":"Neurochem Res"},{"key":"1364_CR45","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.2337\/db09-0916","volume":"60","author":"DE Befroy","year":"2011","unstructured":"Befroy DE, Shulman GI. Magnetic resonance spectroscopy studies of human metabolism. Diabetes. 2011;60:1361\u20139.","journal-title":"Diabetes"},{"key":"1364_CR46","doi-asserted-by":"crossref","unstructured":"Hertz, L and DL Rothman, Glucose, lactate, \u03b2-hydroxybutyrate, acetate, GABA, and succinate as substrates for synthesis of glutamate and GABA in the glutamine\u2013glutamate\/GABA cycle, in The Glutamate\/GABA-Glutamine Cycle. 2016, Springer. p. 9\u201342.","DOI":"10.1007\/978-3-319-45096-4_2"},{"key":"1364_CR47","doi-asserted-by":"crossref","unstructured":"Cuenoud B, Hartweg M, Godin JP, Croteau E, Maltais M, Castellano CA, et al. Metabolism of exogenous D-beta-hydroxybutyrate, an energy substrate avidly consumed by the heart and kidney. Front in Nutr. 2020;7:1\u20139.","DOI":"10.3389\/fnut.2020.00013"},{"key":"1364_CR48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.yrtph.2012.04.008","volume":"63","author":"K Clarke","year":"2012","unstructured":"Clarke K, Tchabanenko K, Pawlosky R, Carter E, Todd King M, Musa-Veloso K, et al. Kinetics, safety and tolerability of (R)\u22123-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regulatory Toxicol Pharmacol. 2012;63:401\u20138.","journal-title":"Regulatory Toxicol Pharmacol"},{"key":"1364_CR49","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.yrtph.2012.04.001","volume":"63","author":"K Clarke","year":"2012","unstructured":"Clarke K, Tchabanenko K, Pawlosky R, Carter E, Knight NS, Murray AJ, et al. Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. Regulatory Toxicol Pharmacol. 2012;63:196\u2013208.","journal-title":"Regulatory Toxicol Pharmacol"},{"key":"1364_CR50","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SW Provencher","year":"1993","unstructured":"Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672\u20139.","journal-title":"Magn Reson Med"},{"key":"1364_CR51","doi-asserted-by":"publisher","first-page":"e4257","DOI":"10.1002\/nbm.4257","volume":"34","author":"J Near","year":"2021","unstructured":"Near J, Harris AD, Juchem C, Kreis R, Marja\u0144ska M, \u00d6z G, et al. Preprocessing, analysis and quantification in single\u2010voxel magnetic resonance spectroscopy: experts\u2019 consensus recommendations. NMR Biomedicine. 2021;34:e4257.","journal-title":"NMR Biomedicine"},{"key":"1364_CR52","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/jmri.24478","volume":"40","author":"RAE Edden","year":"2014","unstructured":"Edden RAE, Puts NAJ, Harris AD, Barker PB, Evans CJ. Gannet: a batch\u2010processing tool for the quantitative analysis of gamma\u2010aminobutyric acid\u2013edited MR spectroscopy spectra. J Magn Reson Imaging. 2014;40:1445\u201352.","journal-title":"J Magn Reson Imaging"},{"key":"1364_CR53","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/jmri.24903","volume":"42","author":"AD Harris","year":"2015","unstructured":"Harris AD, Puts NA, Edden RA. Tissue correction for GABA\u2010edited MRS: considerations of voxel composition, tissue segmentation, and tissue relaxations. J Magn Reson Imaging. 2015;42:1431\u201340.","journal-title":"J Magn Reson Imaging"},{"key":"1364_CR54","doi-asserted-by":"publisher","first-page":"e0177680","DOI":"10.1371\/journal.pone.0177680","volume":"12","author":"N Atassi","year":"2017","unstructured":"Atassi N, Xu M, Triantafyllou C, Keil B, Lawson R, Cernasov P, et al. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis. PLoS One. 2017;12:e0177680.","journal-title":"PLoS One"},{"key":"1364_CR55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc: Ser B (Methodol). 1995;57:289\u2013300.","journal-title":"J R Stat Soc: Ser B (Methodol)"},{"key":"1364_CR56","unstructured":"Team RC, R Core Team R: a language and environment for statistical computing. Foundation for Statistical Computing, 2020."},{"key":"1364_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuron.2010.09.002","volume":"68","author":"N Juge","year":"2010","unstructured":"Juge N, Gray JA, Omote H, Miyaji T, Inoue T, Hara C, et al. Metabolic control of vesicular glutamate transport and release. Neuron. 2010;68:99\u2013112.","journal-title":"Neuron"},{"key":"1364_CR58","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12640-010-9220-0","volume":"20","author":"I Chmiel-Perzy\u0144ska","year":"2011","unstructured":"Chmiel-Perzy\u0144ska I, Kloc R, Perzy\u0144ski A, Rudzki S, Urba\u0144ska EM. Novel aspect of ketone action: \u03b2-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro. Neurotox Res. 2011;20:40\u201350.","journal-title":"Neurotox Res"},{"key":"1364_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuropharm.2018.12.013","volume":"148","author":"NC Pflanz","year":"2019","unstructured":"Pflanz NC, Daszkowski AW, James KA, Mihic SJ. Ketone body modulation of ligand-gated ion channels. Neuropharmacology. 2019;148:21\u201330.","journal-title":"Neuropharmacology"},{"key":"1364_CR60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1528-1167.2008.01841.x","volume":"49","author":"M Yudkoff","year":"2008","unstructured":"Yudkoff M, Daikhin Y, Horyn O, Nissim I, Nissim I. Ketosis and brain handling of glutamate, glutamine, and GABA. Epilepsia. 2008;49:73\u201375.","journal-title":"Epilepsia"},{"key":"1364_CR61","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1471-4159.2009.06115.x","volume":"110","author":"TM Lund","year":"2009","unstructured":"Lund TM, Risa O, Sonnewald U, Schousboe A, Waagepetersen HS. Availability of neurotransmitter glutamate is diminished when \u03b2\u2010hydroxybutyrate replaces glucose in cultured neurons. J neurochemistry. 2009;110:80\u201391.","journal-title":"J neurochemistry"},{"key":"1364_CR62","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2013.00191","volume":"4","author":"MC McKenna","year":"2013","unstructured":"McKenna MC. Glutamate pays its own way in astrocytes. Front Endocrinol. 2013;4:191.","journal-title":"Front Endocrinol"},{"key":"1364_CR63","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1002\/jnr.21444","volume":"85","author":"MC McKenna","year":"2007","unstructured":"McKenna MC. The glutamate\u2010glutamine cycle is not stoichiometric: fates of glutamate in brain. J Neurosci Res. 2007;85:3347\u201358.","journal-title":"J Neurosci Res"},{"key":"1364_CR64","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s11064-012-0901-3","volume":"37","author":"MC McKenna","year":"2012","unstructured":"McKenna MC. Substrate competition studies demonstrate oxidative metabolism of glucose, glutamate, glutamine, lactate and 3-hydroxybutyrate in cortical astrocytes from rat brain. Neurochem Res. 2012;37:2613\u201326.","journal-title":"Neurochem Res"},{"key":"1364_CR65","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/j.1471-4159.2010.06797.x","volume":"114","author":"R Rao","year":"2010","unstructured":"Rao R, Ennis K, Long JD, Ugurbil K, Gruetter R, Tkac I. Neurochemical changes in the developing rat hippocampus during prolonged hypoglycemia. J neurochemistry. 2010;114:728\u201338.","journal-title":"J neurochemistry"},{"key":"1364_CR66","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/jcbfm.2014.32","volume":"34","author":"M Terpstra","year":"2014","unstructured":"Terpstra M, Moheet A, Kumar A, Eberly LE, Seaquist E, \u00d6z G. Changes in human brain glutamate concentration during hypoglycemia: insights into cerebral adaptations in hypoglycemia-associated autonomic failure in type 1 diabetes. J Cereb Blood Flow Metab. 2014;34:876\u201382.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1364_CR67","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2362.2006.01615.x","volume":"36","author":"MG Bischof","year":"2006","unstructured":"Bischof MG, Brehm A, Bernroider E, Krss\u00e1k M, Mlyn\u00e1rik V, Krebs M, et al. Cerebral glutamate metabolism during hypoglycaemia in healthy and type 1 diabetic humans. Eur J Clin Investig. 2006;36:164\u20139.","journal-title":"Eur J Clin Investig"},{"key":"1364_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/bs.irn.2020.03.015","volume":"154","author":"D Kapogiannis","year":"2020","unstructured":"Kapogiannis D, Avgerinos KI. Brain glucose and ketone utilization in brain aging and neurodegenerative diseases. Int Rev Neurobiol. 2020;154:79\u2013110.","journal-title":"Int Rev Neurobiol"},{"key":"1364_CR69","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1177\/0271678X15613955","volume":"36","author":"R Valdebenito","year":"2016","unstructured":"Valdebenito R, et al. Targeting of astrocytic glucose metabolism by beta-hydroxybutyrate. J Cereb Blood Flow Metab. 2016;36:1813\u201322.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1364_CR70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.brainres.2009.02.074","volume":"1268","author":"Y Suzuki","year":"2009","unstructured":"Suzuki Y, Takahashi H, Fukuda M, Hino H, Kobayashi K, Tanaka J, et al. \u03b2-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes. Brain Res. 2009;1268:17\u201323.","journal-title":"Brain Res"},{"key":"1364_CR71","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1007\/s11064-017-2228-6","volume":"42","author":"LB Achanta","year":"2017","unstructured":"Achanta LB, Rowlands BD, Thomas DS, Housley GD, Rae CD. \u03b2-Hydroxybutyrate boosts mitochondrial and neuronal metabolism but is not preferred over glucose under activated conditions. Neurochem Res. 2017;42:1710\u201323.","journal-title":"Neurochem Res"},{"key":"1364_CR72","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11064-016-2099-2","volume":"42","author":"LB Achanta","year":"2017","unstructured":"Achanta LB, Rae CD. \u03b2-Hydroxybutyrate in the brain: one molecule, multiple mechanisms. Neurochem Res. 2017;42:35\u201349.","journal-title":"Neurochem Res"},{"key":"1364_CR73","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/sj.jcbfm.9600453","volume":"27","author":"FA Nasrallah","year":"2007","unstructured":"Nasrallah FA, Griffin JL, Balcar VJ, Rae C. Understanding your inhibitions: modulation of brain cortical metabolism by GABAB receptors. J Cereb Blood Flow Metab. 2007;27:1510\u201320.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1364_CR74","doi-asserted-by":"publisher","first-page":"e62575","DOI":"10.7554\/eLife.62575","volume":"10","author":"EC Porges","year":"2021","unstructured":"Porges EC, Jensen G, Foster B, Edden RA, Puts NA. The trajectory of cortical GABA across the lifespan, an individual participant data meta-analysis of edited MRS studies. Elife. 2021;10:e62575.","journal-title":"Elife"},{"key":"1364_CR75","doi-asserted-by":"crossref","unstructured":"Hone-Blanchet, A, et al., Frontal metabolites and Alzheimer\u2019s disease biomarkers in healthy older women and women diagnosed with mild cognitive impairment. Journal of Alzheimer\u2019s Disease. 2022;87:1131\u201341.","DOI":"10.3233\/JAD-215431"},{"key":"1364_CR76","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2021.09.016","volume":"109","author":"A Hone-Blanchet","year":"2022","unstructured":"Hone-Blanchet A, Bohsali A, Krishnamurthy LC, Shahid S, Lin Q, Zhao L, et al. Relationships between frontal metabolites and Alzheimer\u2019s disease biomarkers in cognitively normal older adults. Neurobiol Aging. 2022;109:22\u201330.","journal-title":"Neurobiol Aging"},{"key":"1364_CR77","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.neubiorev.2019.01.003","volume":"98","author":"C Cleeland","year":"2019","unstructured":"Cleeland C, Pipingas A, Scholey A, White D. Neurochemical changes in the aging brain: a systematic review. Neurosci Biobehav Rev. 2019;98:306\u201319.","journal-title":"Neurosci Biobehav Rev"},{"key":"1364_CR78","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1097\/00004647-200010000-00012","volume":"20","author":"JW Pan","year":"2000","unstructured":"Pan JW, Rothman TL, Behar KL, Stein DT, Hetherington HP. Human brain \u03b2-hydroxybutyrate and lactate increase in fasting-induced ketosis. J Cereb Blood Flow Metab. 2000;20:1502\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1364_CR79","doi-asserted-by":"publisher","first-page":"17404","DOI":"10.1523\/JNEUROSCI.2178-13.2013","volume":"33","author":"F Wang","year":"2013","unstructured":"Wang F, Smith NA, Xu Q, Goldman S, Peng W, Huang JH, et al. Photolysis of caged Ca2+ but not receptor-mediated Ca2+ signaling triggers astrocytic glutamate release. J Neurosci. 2013;33:17404\u201312.","journal-title":"J Neurosci"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01364-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01364-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01364-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T05:57:59Z","timestamp":1727848679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01364-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1038\/s41386-022-01364-8","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AH-B, BA, LMcM, APL, SS, NAS, Y-FY, BGJ and LRM-P declare no conflict of interest. APL is a consultant for Agios Pharmaceuticals, Biomarin Pharmaceuticals, and Moncton MRI; is co-founder of BrainSpec Inc.; and receives research funding from NINDS, NIA, the Department of Defense, and the Alzheimer\u2019s Association. E\u2010MR is a member on the advisory board for BrainSpec, Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}